Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) announced that the Divisional Court of the Ontario Superior Court of Justice has dismissed the appeal brought by Mr. Eugene Melnyk of the Order of the Honourable Justice Wilton-Siegel dismissing Mr. Melnyk’s motion for leave to commence a derivative action in the name of the Company against certain of the Company’s directors and officers.
InMed Pharmaceuticals Inc. ("InMed" or the "Company") (CSE:IN; OTCQB:IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares ("Common Shares") on the TSX.
On February 6, 2018, Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) announced it entered into a non-binding term sheet (the “Term Sheet”) with Martello Finance Company Limited to sell Stellwagen Group Limited (“Stellwagen”) and an amending agreement (the “Amending Agreement”) to its U.S. $150 million credit facility (the “Credit Facility”).
African Gold Group, Inc. (TSX VENTURE:AGG) (“AGG” or the “Company”) is pleased to announce that is has agreed to a private placement into the Company whereby Forbes & Manhattan Resources Inc. (“Forbes”) and certain other investors who will subscribe to a private placement of units (the “Unit”) at a price of $0.09 per Unit for gross proceeds of up to approximately $7.0 million (the “Private Placement”).
EllisDon Civil is pleased to announce that EllisDon Transit Infrastructure (EDTI) has achieved financial close and been awarded the contract to design, build, and finance Metrolinx’s and Infrastructure Ontario’s Regional Express Rail – Stouffville Stations expansion project. “EllisDon Civil is very excited to be delivering this important RER infrastructure,” Said Max Mantha, Vice President and Area Manager for EllisDon Civil.